Concentration Dependent Dual Effect of Thrombin in Endothelial Cells Via Par-1 and Pi3 Kinase

Overview

Journal J Cell Physiol

Specialties Cell Biology
Physiology

Date 2009 Feb 4

PMID 19189342

Citations 37

Authors

Jong-Sup Bae

Yong-Ung Kim

Moon-Ki Park

Alireza R Rezaie

Affiliations

Soon will be listed here.

Abstract

Disruption of endothelial barrier is a critical pathophysiological factor in inflammation. Thrombin exerts a variety of cellular effects including inflammation and apoptosis through activation of the protease activated receptors (PARs). The activation of PAR-1 by thrombin is known to have a bimodal effect in endothelial cell permeability with a low concentration (pM levels) eliciting a barrier protective and a high concentration (nM levels) eliciting a barrier disruptive response. It is not known whether this PAR-1-dependent activity of thrombin is a unique phenomenon specific for the in vitro assay or it is part of a general anti-inflammatory effect of low concentrations of thrombin that may have a physiological relevance. Here, we report that low concentrations of thrombin or of PAR-1 agonist peptide induced significant anti-inflammatory activities. However, relatively high concentration of thrombin or of PAR-1 agonist peptide showed pro-inflammatory activities. By using function-blocking anti-PAR-1 antibodies and PI3 kinase inhibitor, we show that the direct anti-inflammatory effects of low concentrations of thrombin are dependent on the activation of PAR-1 and PI3 kinase. These results suggest a role for cross communication between PAR-1 activation and PI3 kinase pathway in mediating the cytoprotective effects of low concentrations of thrombin in the cytokine-stimulated endothelial cells. J. Cell. Physiol. 219: 744-751, 2009. (c) 2009 Wiley-Liss, Inc.

Citing Articles

Thrombomodulin Switches Signaling and Protease-Activated Receptor 1 Cleavage Specificity of Thrombin.

Biswas I, Giri H, Panicker S, Rezaie A Arterioscler Thromb Vasc Biol. 2024; 44(3):603-616.

PMID: 38174561 PMC: 10922642. DOI: 10.1161/ATVBAHA.123.320185.

Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19.

Tran F, Harris D, Scharmacher A, Grasshoff H, Sterner K, Schinke S ERJ Open Res. 2022; 8(4).

PMID: 36575710 PMC: 9571165. DOI: 10.1183/23120541.00379-2022.

Intracellular communication and immunothrombosis in sepsis.

Iba T, Levi M, Levy J J Thromb Haemost. 2022; 20(11):2475-2484.

PMID: 35979601 PMC: 9804233. DOI: 10.1111/jth.15852.

Protease-activated receptors in health and disease.

Peach C, Edgington-Mitchell L, Bunnett N, Schmidt B Physiol Rev. 2022; 103(1):717-785.

PMID: 35901239 PMC: 9662810. DOI: 10.1152/physrev.00044.2021.

Effects of intermittent hypoxia with thrombin in an in vitro model of human brain endothelial cells and their impact on PAR-1/PAR-3 cleavage.

Zolotoff C, Puech C, Roche F, Perek N Sci Rep. 2022; 12(1):12305.

PMID: 35853902 PMC: 9296553. DOI: 10.1038/s41598-022-15592-x.

References

Macfarlane S, Seatter M, Kanke T, HUNTER G, Plevin R . Proteinase-activated receptors. Pharmacol Rev. 2001; 53(2):245-82. View

Finigan J, Dudek S, Singleton P, Chiang E, Jacobson J, Camp S . Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. J Biol Chem. 2005; 280(17):17286-93. DOI: 10.1074/jbc.M412427200. View

Camerer E, Huang W, Coughlin S . Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A. 2000; 97(10):5255-60. PMC: 25815. DOI: 10.1073/pnas.97.10.5255. View

Majno G, Palade G . Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol. 1961; 11:571-605. PMC: 2225138. DOI: 10.1083/jcb.11.3.571. View

Sugama Y, Tiruppathi C, offakidevi K, Andersen T, Fenton 2nd J, Malik A . Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion. J Cell Biol. 1992; 119(4):935-44. PMC: 2289699. DOI: 10.1083/jcb.119.4.935. View

Weinstein J, Gold S, Cunningham D, Gall C . Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J Neurosci. 1995; 15(4):2906-19. PMC: 6577761. View

Colotta F, Sciacca F, Sironi M, Luini W, Rabiet M, Mantovani A . Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Pathol. 1994; 144(5):975-85. PMC: 1887349. View

Che W, Lerner-Marmarosh N, Huang Q, Osawa M, Ohta S, Yoshizumi M . Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ Res. 2002; 90(11):1222-30. DOI: 10.1161/01.res.0000021127.83364.7d. View

Sambrano G, Weiss E, Zheng Y, Huang W, Coughlin S . Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature. 2001; 413(6851):74-8. DOI: 10.1038/35092573. View

10.

Ishihara H, Connolly A, Zeng D, Kahn M, Zheng Y, Timmons C . Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 1997; 386(6624):502-6. DOI: 10.1038/386502a0. View

11.

Kim I, Moon S, Kim S, Kim H, Koh Y, Koh G . Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem. 2000; 276(10):7614-20. DOI: 10.1074/jbc.M009705200. View

12.

Donovan F, Pike C, Cotman C, Cunningham D . Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci. 1997; 17(14):5316-26. PMC: 6793831. View

13.

Naldini A, Carney D . Thrombin modulation of natural killer activity in human peripheral lymphocytes. Cell Immunol. 1996; 172(1):35-42. DOI: 10.1006/cimm.1996.0212. View

14.

Vu T, Hung D, Wheaton V, Coughlin S . Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991; 64(6):1057-68. DOI: 10.1016/0092-8674(91)90261-v. View

15.

Grandaliano G, Valente A, Abboud H . A novel biologic activity of thrombin: stimulation of monocyte chemotactic protein production. J Exp Med. 1994; 179(5):1737-41. PMC: 2191479. DOI: 10.1084/jem.179.5.1737. View

16.

Coughlin S . Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost. 2005; 3(8):1800-14. DOI: 10.1111/j.1538-7836.2005.01377.x. View

17.

Feistritzer C, Riewald M . Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood. 2005; 105(8):3178-84. DOI: 10.1182/blood-2004-10-3985. View

18.

Nierodzik M, Kajumo F, Karpatkin S . Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res. 1992; 52(12):3267-72. View

19.

Komarova Y, Mehta D, Malik A . Dual regulation of endothelial junctional permeability. Sci STKE. 2007; 2007(412):re8. DOI: 10.1126/stke.4122007re8. View

20.

Kayanoki Y, Higashiyama S, Suzuki K, Asahi M, Kawata S, Matsuzawa Y . The requirement of both intracellular reactive oxygen species and intracellular calcium elevation for the induction of heparin-binding EGF-like growth factor in vascular endothelial cells and smooth muscle cells. Biochem Biophys Res Commun. 1999; 259(1):50-5. DOI: 10.1006/bbrc.1999.0723. View